The Latest Mammography Industry Statistics Explained
Mammography services have an estimated market value of USD 2.08 billion in 2020.
The statistic “Mammography services have an estimated market value of USD 2.08 billion in 2020” indicates the total monetary worth associated with the provision of mammography screening and diagnostic services within the healthcare industry in the year 2020. This figure reflects the revenue generated by healthcare facilities, radiology centers, and other providers offering mammography services to detect and diagnose breast cancer. The market value of USD 2.08 billion underscores the significant economic contribution of mammography services to the healthcare sector, highlighting the demand for early detection and prevention of breast cancer among women worldwide.
The industry is foreseen to expand at a CAGR of 7.4% over 2021 to 2028 period.
The statement “The industry is foreseen to expand at a Compound Annual Growth Rate (CAGR) of 7.4% over the period from 2021 to 2028” means that it is expected that the industry will grow consistently at a rate of 7.4% per year on average throughout the specified time frame. CAGR is a useful metric for understanding the average annual growth rate of an industry, as it smoothens out fluctuations and provides a single growth rate that can be easily compared across different time periods. This forecast suggests that the industry is projected to experience steady and sustained growth over the next seven years, highlighting potential opportunities for investment and development within the sector.
2D mammography segment accounted for the largest share, 41.3%, of the global market in 2020.
The statistic indicates that in 2020, the 2D mammography segment held the highest market share compared to other types of mammography technologies. Specifically, the 2D mammography segment accounted for 41.3% of the global market, suggesting that this technology was the most widely used or preferred by healthcare providers and patients for breast cancer screening and diagnosis. This statistic implies that 2D mammography remains a significant player in the mammography market, despite the availability of newer technologies like 3D mammography, highlighting its continued relevance and popularity in the healthcare industry.
North America dominated the mammography market in 2020 with a share of 32.63%.
The statistic “North America dominated the mammography market in 2020 with a share of 32.63%” indicates that North America accounted for the largest portion of the mammography market compared to other regions in 2020. This means that approximately 32.63% of all mammography procedures or equipment sales globally were attributed to North America. This dominance suggests that North America had a significant influence and impact on the mammography market that year, potentially driven by factors such as technological advancements, healthcare infrastructure, and overall awareness and access to breast cancer screening in the region.
Approximately 48 million mammograms are performed each year in the United States.
The statistic stating that approximately 48 million mammograms are performed each year in the United States highlights the widespread use and importance of breast cancer screening in the country. Mammograms are a critical tool for detecting breast cancer at an early stage when treatment is most effective, making them a key component of public health initiatives aimed at reducing breast cancer mortality rates. This statistic underscores the significant efforts and resources dedicated to promoting regular screening and early detection of breast cancer in the United States to improve health outcomes and save lives.
By 2026, the mammography market is expected to reach USD 3.51 Billion.
The statistic “By 2026, the mammography market is expected to reach USD 3.51 Billion” indicates the projected total value of the mammography market in terms of revenue by the year 2026. This figure represents the anticipated financial size of the market dedicated to mammography equipment and services, including screening and diagnostic procedures related to breast health. Such projections are typically based on market research, analysis of current trends, historical data, and future forecasts related to factors that influence the demand for mammography services. The substantial monetary amount of USD 3.51 Billion suggests a significant and growing market opportunity for stakeholders in the mammography industry, including healthcare providers, medical device manufacturers, researchers, policymakers, and investors.
Population aged 50 and above drive mammography market as 80% of breast cancers occur in women age 50 and older.
The statistic suggests that the population aged 50 and above play a significant role in driving the mammography market, as around 80% of breast cancer cases are diagnosed in women aged 50 and older. This indicates that the demographic group of individuals aged 50 and above is heavily impacted by breast cancer and therefore has a higher demand for mammography services for early detection and diagnosis. This statistic highlights the importance of targeting this specific age group in the promotion and utilization of mammography services to effectively address the high incidence of breast cancer among older women.
Up to 50% of women report significant short-term anxiety or distress before a mammogram.
This statistic indicates that a significant proportion of women, up to 50%, experience notable levels of anxiety or distress in the short term before undergoing a mammogram, a routine screening test for breast cancer. The emotional response of anxiety or distress can be anticipated in many women due to various factors such as fear of the unknown, concerns about potential outcomes, or discomfort associated with the procedure. This statistic highlights the importance of considering the emotional well-being of women undergoing mammograms and the potential need for additional support and information to help address their anxiety and distress levels. Effective communication, education, and support services may play a critical role in alleviating these pre-screening emotions and enhancing the overall mammogram experience for women.
There were about 18,807 registered mammography facilities in the U.S in 2021.
The statistic that there were about 18,807 registered mammography facilities in the U.S. in 2021 indicates the significant number of healthcare facilities dedicated to offering mammograms, which are crucial for early detection and screening of breast cancer. This high volume reflects the emphasis placed on promoting women’s health and highlights the accessibility of mammography services across the country. The availability of such a large number of facilities suggests that many individuals have access to potentially life-saving screening services, contributing to efforts to improve early detection rates and overall health outcomes related to breast cancer in the United States.
An estimated 2,323,994 mammographic exams were done in digital mammography units in 2021.
The statistic ‘An estimated 2,323,994 mammographic exams were done in digital mammography units in 2021’ suggests that a significant number of mammograms were performed using digital technology in the year 2021. Given the high volume of exams, it indicates the widespread utilization of digital mammography units in healthcare facilities for the detection and screening of breast cancer. This statistic highlights the importance of early detection and monitoring of breast health, as mammograms are crucial for identifying potential abnormalities and guiding further diagnostic procedures. The large number of exams also underscores the commitment of healthcare providers to promoting women’s health and preventing breast cancer through regular screenings.
3D mammography market is expected to reach USD 4.25 billion by 2027.
The statistic ‘3D mammography market is expected to reach USD 4.25 billion by 2027’ indicates the projected value of the market for three-dimensional (3D) mammography technology by the year 2027. This forecast suggests a significant growth in adoption and revenue generation for 3D mammography equipment and services in the healthcare industry. Factors such as increased awareness of the benefits of 3D mammography in detecting breast cancer, technological advancements in imaging technology, and rising prevalence of breast cancer globally are likely to drive this market growth. The estimated market value of USD 4.25 billion indicates the expected size and scale of opportunities within the 3D mammography market by 2027.
The number of mammogram facilities in the US increased from 16685 in 2011 to 18807 in 2021.
The statistic indicates a noticeable increase in the number of mammogram facilities in the United States over the ten-year period from 2011 to 2021. The rise from 16,685 facilities in 2011 to 18,807 facilities in 2021 suggests a growing availability of mammogram services to the population. This expansion may be attributed to various factors such as increased awareness about the importance of breast cancer screening, advancements in medical technology, and potentially increased funding or support for healthcare services related to breast health. The upward trend in the number of mammogram facilities implies improved access to early detection and screening services for breast cancer, which is crucial for timely diagnosis and treatment.
In Germany, the mammography screening program reaches about 2.9 million women annually.
The statistic indicates that in Germany, around 2.9 million women participate in the mammography screening program each year. Mammography screening is a method of early detection of breast cancer through X-ray imaging of the breast tissue. This statistic suggests a widespread uptake of the screening program among the female population in Germany, reflecting awareness of the importance of regular breast cancer screening and a proactive approach to women’s health. The high number of participants also implies that a significant portion of the target population is benefiting from early detection, potentially leading to better treatment outcomes and reduced mortality rates from breast cancer.
Portable mammography devices market is projected to grow by USD 1.02 billion during 2021-26.
The statistic indicates that the portable mammography devices market is forecasted to experience significant growth with an estimated increase in value of USD 1.02 billion between the years 2021 and 2026. This projection suggests a positive trend in the demand for portable mammography devices, which are used for breast imaging in a more accessible and convenient manner compared to traditional fixed units. Factors contributing to this market growth could include advancements in technology, rising awareness about breast cancer screening, and increasing adoption of portable medical devices in healthcare settings. This projected growth signifies potential opportunities for manufacturers, healthcare providers, and other stakeholders in the portable mammography devices industry.
Mammography screening rates dropped significantly by 89% due to COVID-19 pandemic in April 2020 in the US.
The statistic indicates a substantial and concerning drop in mammography screening rates during April 2020 in the US, specifically by 89% due to the impact of the COVID-19 pandemic. This sharp decline highlights the profound influence of the pandemic on healthcare services and preventive care measures, with many individuals likely postponing or forgoing routine mammograms due to fears of exposure to the virus or disruptions in healthcare services. The significant decrease in mammography screening rates suggests a potential delay in cancer detection and diagnosis, which could have long-term implications on public health and outcomes for individuals with breast cancer. Efforts may be needed to address this decline and encourage individuals to prioritize their preventive health screenings to ensure timely detection and treatment of breast cancer.
3D technology is forecasted to expand at the fastest CAGR of 8.5% from 2021 to 2028.
This statistic indicates that the 3D technology industry is projected to experience significant growth over the period from 2021 to 2028, with a Compound Annual Growth Rate (CAGR) of 8.5%. A CAGR of 8.5% means that the industry’s revenue or market size is expected to increase by 8.5% on average each year during this time frame. This forecast suggests strong demand and adoption of 3D technology across various sectors such as entertainment, healthcare, manufacturing, and architecture. The rapid expansion of 3D technology can be attributed to advancements in hardware and software capabilities, increasing consumer interest, and the growing applications of 3D technology in different industries, positioning it as one of the fastest-growing segments in the tech industry.
Europe is anticipated to be the second-largest market in the mammography industry due to the high incidence rate of breast cancer.
The statistic highlights that Europe is expected to be the second-largest market in the mammography industry, primarily driven by the region’s high incidence rate of breast cancer. Breast cancer is a significant health concern globally, and Europe has been experiencing a high prevalence of this disease. The demand for mammography services in Europe is consequently expected to be substantial, leading to growth in the mammography industry within the region. This statistic underscores the importance of early detection and screening efforts to address the prevalence of breast cancer in Europe and the need for healthcare services and technologies like mammography to effectively tackle this public health issue.
Asia Pacific market is anticipated to witness lucrative growth over the forecasted period, at a CAGR of 8.1%.
This statistic indicates that the Asia Pacific market is expected to experience strong and continuous growth over the forecasted period, with a Compound Annual Growth Rate (CAGR) of 8.1%. A CAGR of 8.1% suggests that the market is projected to expand steadily at an annual rate of 8.1% over the specified time frame. This growth rate signifies a significant opportunity for businesses and investors operating in the Asia Pacific region, as it implies an increasing demand for goods and services, potential market expansion, and attractive investment prospects. Overall, this statistic highlights the promising outlook for the Asia Pacific market and underscores its potential as a lucrative destination for business growth and investment.
The global mammographic X-ray unit manufacturing market is projected to reach $3.7 billion in 2021.
This statistic indicates that the global market for manufacturing mammographic X-ray units is expected to reach a total value of $3.7 billion in the year 2021. This suggests a significant demand for mammographic X-ray units worldwide, likely driven by factors such as an increasing need for early detection of breast cancer and advancements in healthcare technology. The projected market value reflects the anticipated sales and revenue generated by companies involved in the manufacturing and distribution of mammographic X-ray units, highlighting the growing importance of this medical imaging technology in the healthcare industry globally.
The top five organizations held 89.1% market share in the mammography machine market in 2019.
The statistic indicates that the top five organizations in the mammography machine market collectively accounted for a significant portion of the market share, specifically 89.1%. This suggests that these five organizations dominate the industry and have a strong competitive position in comparison to other companies operating in the market. The market concentration within the top five players signifies a high level of control and influence they have over market dynamics, such as pricing, innovation, and market trends. This data highlights the intense competition and challenges for smaller and newer players to establish themselves in the mammography machine market against these established top organizations.
References
0. – https://www.www.grandviewresearch.com
1. – https://www.www.statista.com
2. – https://www.www.fda.gov
3. – https://www.www.technavio.com
4. – https://www.www.thebusinessresearchcompany.com
5. – https://www.www.cancer.org
6. – https://www.www.ncbi.nlm.nih.gov
7. – https://www.www.globenewswire.com
8. – https://www.www.sciencedaily.com
9. – https://www.www.fortunebusinessinsights.com
10. – https://www.jamanetwork.com
11. – https://www.www.industrie.de
12. – https://www.www.marketdataforecast.com
